Stage III Rectal Cancer AJCC V8

general

Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonpe

71

Centers

137

Active Trials

$105M

Cancer Funding

Specific Cancer Types(2)

Top Centers for Stage III Rectal Cancer AJCC V8(71)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.9
2
High-Volume Research Center
72.2
3
NCI Comprehensive
High-Volume Research Center
70.6
4
NCI Comprehensive
High-Volume Research Center
70.6
5
NCI Comprehensive
High-Volume Research Center
70.6
6
NCI Comprehensive
High-Volume Research Center
70.6
7
NCI Comprehensive
Active Research Program
64.1
8
NCI Comprehensive
Active Research Program
64.1
9
NCI Comprehensive
Active Research Program
64.1
10
NCI Comprehensive
Active Research Program
64.1
11
NCI Comprehensive
Active Research Program
64.1
12
NCI Comprehensive
Active Research Program
64.1
13
NCI Clinical
Active Research Program
64.1
14
NCI Clinical
Active Research Program
64.1
15
NCI Comprehensive
Active Research Program
64.1
16
NCI Comprehensive
Active Research Program
64.1
17
NCI Clinical
Active Research Program
64.1
18
Active Research Program
64.1
19
Active Research Program
64.1
20
Active Research Program
64.1
21
Active Research Program
64.1
22
Active Research Program
64.1
23
NCI Comprehensive
Active Research Program
53.0
24
NCI Comprehensive
Active Research Program
53.0
25
NCI Comprehensive
Active Research Program
53.0
26
NCI Comprehensive
Active Research Program
53.0
2753.0
28
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
53.0
29
NCI Comprehensive
Active Research Program
53.0
30
NCI Comprehensive
Active Research Program
53.0
31
NCI Comprehensive
Active Research Program
53.0
32
NCI Comprehensive
Active Research Program
53.0
33
NCI Comprehensive
Active Research Program
53.0
34
NCI Comprehensive
Active Research Program
53.0
35
Active Research Program
53.0
36
Active Research Program
53.0
3753.0
3853.0
39
Active Research Program
53.0
40
Active Research Program
53.0
41
NCI Comprehensive
Active Research Program
38.7
42
NCI Comprehensive
Active Research Program
38.7
43
NCI Comprehensive
Active Research Program
38.7
44
NCI Comprehensive
Active Research Program
38.7
45
NCI Comprehensive
Active Research Program
38.7
46
NCI Comprehensive
Active Research Program
38.7
47
NCI Comprehensive
Active Research Program
38.7
48
NCI Comprehensive
Active Research Program
38.7
49
NCI Comprehensive
Active Research Program
38.7
50
NCI Comprehensive
Active Research Program
38.7
51
NCI Comprehensive
Active Research Program
38.7
52
NCI Comprehensive
Active Research Program
38.7
53
Active Research Program
38.7
54
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
38.7
55
Active Research Program
38.7
56
NCI Clinical
Active Research Program
38.7
57
Active Research Program
38.7
58
NCI Comprehensive
Active Research Program
38.7
59
NCI Comprehensive
Active Research Program
38.7
60
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
38.7
61
NCI Comprehensive
Active Research Program
38.7
62
Active Research Program
38.7
63
NCI Basic_laboratory
Active Research Program
38.7
64
Active Research Program
38.7
65
Active Research Program
38.7
66
Active Research Program
38.7
67
NCI Comprehensive
29.2
68
NCI Comprehensive
29.2
69
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
29.2
70
NCI Comprehensive
71

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →